Brief: Lipigon Pharmaceuticals Decides On Rights Issue Of Units Of About SEK 35.4 Mln

Lipigon Pharmaceuticals AB

28/02/2023 11:22

Feb 28 (Reuters) - Lipigon Pharmaceuticals AB  LPGO.ST :
    * DECIDES ON RIGHTS ISSUE OF UNITS OF ABOUT SEK 35.4 MILLION
    * SUBSCRIPTION PRICE IN RIGHTS ISSUE AMOUNTS TO SEK 3.50 PER
UNIT,
WHICH CORRESPONDS TO A SUBSCRIPTION PRICE OF SEK 0.50 PER SHARE
    * RIGHTS ISSUE COMPRISES A MAXIMUM OF 10,122,212 UNITS,
CORRESPONDING TO A MAX OF 70,855,484 SHARES, A MAX OF 60 733,272
WARRANTS OF SERIES TO2 AND A MAX OF 30,366,636 WARRANTS OF
SERIES TO3

Source text for Eikon:  ID:nBQNc0MM8Z 
Further company coverage:  LPGO.ST 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))